Paper Details

  1. Home
  2. Paper Details

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Author: CarterH Ballentine

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Practice GuidelineGuidelines and recommendations for the diagnosis and treatment of specific medical conditions in medical practice.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

The American Urological Association (AUA) recommends shared decision-making for men aged 55-69 years who are considering PSA-based screening for prostate cancer. The AUA does not recommend routine screening for other age groups.
Paper Details　
Original Abstract of the Article :
To review the process and rationale for the American Urological Association (AUA) guideline on prostate cancer detection. The AUA guideline on detection of prostate cancer involved a systematic literature review of >300 studies that evaluated outcomes important to patients (prostate cancer, incidenc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/bju.12318

データ提供：米国国立医学図書館（NLM）

Prostate Cancer Detection: A Guide for Shared Decision-Making

Prostate cancer is a common concern for men, and the decision of whether or not to undergo screening for this disease can be complex. This research presents the American Urological Association (AUA) guideline on prostate cancer detection, outlining the process and rationale behind their recommendations. Based on a comprehensive review of over 300 studies, the AUA guideline recommends shared decision-making for men aged 55-69 years considering prostate-specific antigen (PSA)-based screening. This recommendation emphasizes the importance of involving patients in the decision-making process and carefully weighing the potential benefits and harms of screening.

Navigating the Complexities of Prostate Cancer Screening

The AUA guideline is a valuable resource for healthcare providers and patients, helping to navigate the complex decisions surrounding prostate cancer screening. The guideline recommends against routine screening for men outside of the age range of 55-69 years, and discourages annual screening for those who choose to undergo PSA-based screening. These recommendations are aimed at reducing the risks of false positive tests, overdiagnosis, and overtreatment associated with prostate cancer screening.

Making Informed Decisions About Prostate Cancer Screening

This research emphasizes the importance of open and informed dialogue between patients and their healthcare providers regarding prostate cancer screening. Understanding the potential benefits and harms of screening is crucial for making informed decisions that align with individual preferences and risk factors. It's like navigating a desert landscape, where every step requires careful consideration and awareness of the terrain.

Dr.Camel's Conclusion

This study highlights the importance of shared decision-making in healthcare. It provides a framework for open and collaborative conversations between patients and their doctors, empowering patients to make informed choices that align with their individual needs and priorities.

Date :
  1. Date Completed 2013-11-13
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

23924423

DOI: Digital Object Identifier

10.1111/bju.12318

Related Literature

Article Analysis
・Effective treatment of prostate cancer screening
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.